The vascular protective effects of trihoney in hypercholesterolemic atherosclerotic rabbits, a comparative study with atorvastatin

References

• Alfarisi HAH, Mohamed ZBH, Bin IM. Basic pathogenic mechanisms of atherosclerosis. Egypt J Basic Appl Sci. 2020;7(1):116–125.
   Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695.
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A, Di Raimondo D, Di Sciacca R, et al. Arterial stiffness and ischemic stroke in subjects with and without metabolic syndrome. Atherosclerosis. 2012;225(1):216–219.
   PubMed Web of Science ®Google Scholar
• Moore KJ, Tabas I. The cellular biology of macrophages in atherosclerosis. Cell. 2011;145(3):341–355.
   PubMed Web of Science ®Google Scholar
• Oikonomou E, Latsios G, Vogiatzi G, et al. Atherosclerotic Plaque. In: Dimitris Tousoulis, editor. Coronary artery disease. 1st ed. Athens, Greece: Elsevier Inc.; 2018. p. 31–41.
   Google Scholar
• Tomkin G. LDL as a Cause of Atherosclerosis. Open Atheroscler Thromb J. 2012;5(1)):13–21.
   Google Scholar
• Lorkowski S, Atherosclerosis: CP, Pathogenesis C. Features and Treatment. Encycl Life Sci. 2007;1–11. DOI:10.1002/9780470015902.a0004228.
   Google Scholar
• Bergheanu SC, Bodde MC, Jukema JW. Pathophysiology and treatment of atherosclerosis: current view and future perspective on lipoprotein modification treatment. Netherlands Heart J. 2017;25(4):231–242.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Nagayama M, Suga T, et al. Characterization of atherosclerotic plaque of carotid arteries with histopathological correlation: vascular wall MR imaging vs. color Doppler ultrasonography (US). J Magn Reson Imaging. 2008;28(2):478–485.
   Google Scholar
• Sakakura K, Nakano M, Otsuka F, et al. Pathophysiology of atherosclerosis plaque progression. Heart Lung Circ. 2013;22(6):399–411.
   PubMed Web of Science ®Google Scholar
• Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. 2008;517–27. J Int Med. 2008;263(517–527). DOI:10.1111/j.1365-2796.2008.01965.x
   Google Scholar
• Adiguzel E, Ahmad PJ, Franco C, et al. Collagens in the progression and complications of atherosclerosis. Vasc Med. 2009;14:73–89.
   PubMed Web of Science ®Google Scholar
• Majtanova N, Cernak M, Honey: MJ, et al. Remedy for eye diseases. Forschende Komplementarmed. 2016;23(6):1–6.
   Google Scholar
• Spilioti E, Jaakkola M, Tolonen T, et al. Phenolic acid composition, antiatherogenic and anticancer potential of honeys derived from various regions in Greece. PLoS One. 2014;9(4):1–10.
   Google Scholar
• Vallianou N, Gounari P, Skourtis A, et al. Honey and its anti-inflammatory, anti-bacterial and anti-oxidant properties. Gen Med. 2014;02(2). DOI:10.4172/2327-5146.1000132
   Google Scholar
• Abd Jalil MA, Kasmuri AR, Hadi H. Stingless bee honey, the natural wound healer: a review. Skin Pharmacol Physiol. 2017;30(2):66–75.
   PubMed Web of Science ®Google Scholar
• Sahhugi Z, Hasenan SM, Jubri Z. Protective effects of gelam honey against oxidative damage in young and aged rats. Oxid Med Cell Longev. 2014;2014:1–8.
   Google Scholar
• Erejuwa OO, Sulaiman SA, Wahab MS, et al. Antioxidant protection of Malaysian tualang honey in pancreas of normal and streptozotocin-induced diabetic rats. Ann Endocrinol (Paris). 2010;71(4):291–296.
   PubMed Web of Science ®Google Scholar
• Alfarisi HAS, Ibrahim M, Mohamed ZB, et al. Trihoney suppresses soluble adhesion molecules (ICAM-1 and VCAM-1 in hypercholesterolemic atherosclerotic rabbits: a comparative study with atorvastatin. Sains Malaysiana. 2020;49(6):1313–1322.
   Google Scholar
• Alfarisi HAH, Bin IM, Mohamed ZBH, et al. Hepatoprotective effects of a novel trihoney against nonalcoholic fatty liver disease: a comparative study with atorvastatin. Sci World J. 2020;2020:1–14.
   Google Scholar
• Alfarisi HAH, Bin IM, Azahari N, et al. Anti-inflammatory effects of trihoney in hypercholesterolemic atherosclerotic rabbits: a comparative study with atorvastatin. Malaysian J Med Heal Sci. 2020;16(2):230–236.
   Google Scholar
• Alfarisi HAH, Ibrahim M, Mohamed ZBH, et al. Trihoney reduces lipid peroxidation and enhances antioxidant enzyme activities in hypercholesterolaemic atherosclerotic rabbits. Int Food Res J. 2020;27(3):568–575.
   Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2007;22(3):659–661.
   PubMed Web of Science ®Google Scholar
• Du B, Xu G, Cao H, et al. Effects of atorvastatin on expression of ICAM-1 in atherosclerotic rabbits. J Cardiovasc Med. 2013;14(2):120–126.
   Google Scholar
• Jorge PAR, De AEA, Ozaki MR, et al. Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits. Arq Bras Cardiol. 2005;84(4):314–319.
   PubMedGoogle Scholar
• Song X, Liu H, Wang X, et al. Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium function. Lipids Health Dis. 2014;13(1):1–5.
   Google Scholar
• Animal Ethics Policy Committee (AEPC). International Islamic University Malaysia Animal Ethics Policy. Kuantan; 2012. 14 p. Report No.:387 (21/12/2012).
   Google Scholar
• Rj de A T, de Noronha L, Torres RDRDA, et al. Increased intercellular adhesion molecule-1 immunoreactivity in the sclera-choroid complex in hypercholesterolemia experimental model. Rev Bras Oftalmol. 2014;73(4):210–215.
   Google Scholar
• Bolayirli IM, Aslan M, Balci H, et al. Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine. Life Sci. 2007;81(2):121–127.
   PubMed Web of Science ®Google Scholar
• Fan J, Shimoyamada H, Sun H, et al. Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet. Arter Thromb Vasc Biol. 2001;21(1):88–94.
   Google Scholar
• Gourdon J. Large animal euthanasia. McGill University. Comparative Medicine & Animal Resources Centre. 2008. 2 p. Report No: 302.01.
   Google Scholar
• Mohanta S, Yin C, Weber C, et al. Aorta atherosclerosis lesion analysis in hyperlipidemic mice. Bio-Protocol. 2016;6(11):1–15.
   Google Scholar
• Li H, Cybulsky MI, Gimbrone MA, et al. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 1993;13(2):197–204.
   PubMedGoogle Scholar
• Yu Q, Li Y, Waqar AB, et al. Temporal and quantitative analysis of atherosclerotic lesions in diet-induced hypercholesterolemic rabbits. J Biomed Biotechnol. 2012;2012:1–7.
   PubMedGoogle Scholar
• Ibrahim M, Ahmed IA, Mikail MA, et al. Baccaurea angulata fruit juice reduces atherosclerotic lesions in diet-induced Hypercholesterolemic rabbits. Lipids Health Dis. 2017;16(1):1–8.
   Google Scholar
• Zhang C, Zheng H, Yu Q, et al. A practical method for quantifying atherosclerotic lesions in rabbits. J Comp Pathol. 2010;142(2–3):122–128.
   Google Scholar
• Thent ZC, Lin TS, Das S, et al. Histological changes in the heart and the proximal aorta in experimental diabetic rats fed with Piper sarmentsoum. African J Tradit Complement Altern Med. 2012;9(3):396–404.
   Google Scholar
• Phinikaridou A, Hallock KJ, Qiao Y, et al. A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res. 2009;50(5):787–797.
   Google Scholar
• Scholtes VPW, Johnson JL, Jenkins N, et al. Carotid atherosclerotic plaque matrix metalloproteinase-12-positive macrophage subpopulation predicts adverse outcome after endarterectomy. J Am Heart Assoc. 2012;1(6):1–12.
   Google Scholar
• Luo F, Guo Y, Ruan GY, et al. Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet. Sci Rep. 2017;7(1):1–10.
   PubMedGoogle Scholar
• Aziz M, Yadav K. Pathogenesis of Atherosclerosis A Review. Med Clin Rev. 2016;2(3):1–6.
   Google Scholar
• Tham DM, Martin-McNulty B, Wang Y-X, et al. Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice. Am J Physiol Integr Comp Physiol. 2002;283(6):R1442–9.
   Google Scholar
• Van TBW, Toldo S, Mezzaroma E, et al. Targeting interleukin-1 in heart disease. Circulation. 2014;128(22):1910–1923.
   Google Scholar